Karyopharm Announces FDA Approval of XPOVIO® (selinexor) for the Treatment of Patients with Relapsed or Refractory
Karyopharm Therapeutics Angeforderte Firma
Karyopharm is an innovation-driven pharmaceutical company whose core technology leverages the inhibition of nuclear export as a mechanism to treat patients with cancer and other medical conditions Weiterlesen
Very fast paced, challenging but rewarding
Was macht Sie bei der Arbeit am glücklichsten?
Interacting with my coworkers and driving performance
Was gefällt dir am besten am Führungsteam?
Passion, sense of urgency putting patients first!
Was sind einige der besten Dinge an Ihrem Team?
Creative, dedicated and with a sense of urgency
Was ist am positivsten an Kultur und Umgang in Ihrem Unternehmen?
The people and level of commitment
Was ist das Beste an Ihrem Vergütungspaket?
Base salary, equity and bonus
Other Employee Reviews for Karyopharm Therapeutics
×